HIVEP3 Activators
HIVEP3 activators are a diverse set of chemical compounds that indirectly bolster the functional activity of HIVEP3 by engaging with and modifying signaling pathways critical for its activation. Forskolin and its analog Forskolin-Coleonol, by increasing cAMP, act as catalysts for PKA activation, which in turn can phosphorylate and enhance the activity of HIVEP3, pivotal in the regulation of gene expression. The persistent elevation of cAMP levels is also achieved by 3-Isobutyl-1-methylxanthine (IBMX) and Rolipram, which inhibit cAMP degradation, therefore sustaining PKA activity and indirectly promoting HIVEP3 activation. Similarly, Dibutyryl-cAMP, by directly activating PKA, could enhance HIVEP3 activity, suggesting a potential amplification of HIVEP3's role in transcriptional control. Moreover, EGCG and Curcumin exert their effects by inhibiting other protein kinases, potentially reducing competitive phosphorylation and allowing PKA-mediated phosphorylation of HIVEP3 to prevail.
Sphingosine-1-phosphate and A23187, operating through G-protein coupled receptors and calcium ionophores respectively, activate downstream kinases such as PKA or calcium-dependent kinases, which may result in enhanced HIVEP3 activity through phosphorylation. PMA, as a PKC activator, might also phosphorylate intermediates that influence HIVEP3 activity, thereby supporting its role in gene regulation. Curcumin, by inhibiting NF-κB, could free up coactivators necessary for HIVEP3's function, indirectly potentiating its activity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, leading to increased levels of cyclic AMP (cAMP). Elevated cAMP in turn activates PKA, which can phosphorylate transcription factors including HIVEP3, enhancing its functional activity in gene regulation. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
This compound inhibits phosphodiesterases, preventing the breakdown of cAMP. The resulting increase in cAMP levels can lead to activation of PKA, which may enhance HIVEP3 activity by phosphorylation. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is known to inhibit several protein kinases. This inhibition can reduce competitive phosphorylation events, potentially leading to an increase in PKA activity and subsequent phosphorylation and activation of HIVEP3. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin can inhibit NF-κB signaling. By inhibiting NF-κB, curcumin may indirectly enhance the activity of HIVEP3, as NF-κB can sequester coactivators required by HIVEP3 for its gene regulatory functions. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate activates G-protein coupled receptors, leading to downstream signaling that includes PKA activation. PKA can then enhance HIVEP3 activity through phosphorylation. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram inhibits phosphodiesterase 4 (PDE4), leading to an increase in cAMP levels. This increase can indirectly enhance HIVEP3 activity through PKA-mediated pathways. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a PKC activator. PKC can phosphorylate intermediates that modulate transcription factor activity, potentially leading to enhanced HIVEP3 activity. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is a calcium ionophore that increases intracellular calcium levels, which may activate calcium-dependent protein kinases that can indirectly enhance HIVEP3 activity by phosphorylation. | ||||||
Adenosine 3′,5′-cyclic monophosphate | 60-92-4 | sc-217584 sc-217584A sc-217584B sc-217584C sc-217584D sc-217584E | 100 mg 250 mg 5 g 10 g 25 g 50 g | $116.00 $179.00 $265.00 $369.00 $629.00 $1150.00 | ||
Dibutyryl-cAMP is a cAMP analog that activates PKA. The activation of PKA can lead to phosphorylation of transcription factors, potentially enhancing the activity of HIVEP3. | ||||||